Skip to main content
. 2020 Dec 14;61(1):157–169. doi: 10.1111/head.14026

FIGURE 3.

FIGURE 3

Effect of erenumab on headache in those with and without previous migraine and medication overuse headache. Change in mean number of monthly moderate/severe headache days from baseline to 3, 6, 9, and 12 months. Error bars represent 95% confidence intervals (CIs). (A) Patients with migraine diagnosis prior to IIH diagnosis. (B) Patients without migraine diagnosis prior to IIH diagnosis. (C) Patients with MOH at baseline. (D) Patients without MOH at baseline. IIH, idiopathic intracranial hypertension; MOH, medication overuse headache. ***p < 0.001 compared to baseline [Color figure can be viewed at wileyonlinelibrary.com]